Galliuc

Gallium (68ga) Chloride is a radiopharmaceutical used in diagnostic imaging. It is administered intravenously and is manufactured by Icnas Pharma, Unipessoal, Lda. in the EU.

Gallium (68ga) Chloride is primarily used in positron emission tomography (PET) imaging. This radiopharmaceutical helps in the visualization and assessment of various conditions, including certain types of cancer and inflammatory diseases. It is often utilized to identify areas of abnormal metabolic activity, aiding in the diagnosis and management of these conditions.

Gallium (68ga) Chloride is designed to be used in diagnostic imaging procedures. When administered, it can help highlight specific areas of interest within the body, allowing healthcare professionals to gather detailed images. The effects are typically observed through imaging techniques and are used to support clinical decisions.

As with any radiopharmaceutical, Gallium (68ga) Chloride should be handled with care. It is important to follow the guidelines provided by healthcare professionals and the manufacturer. Proper storage and disposal procedures should be adhered to, ensuring safety for both the patient and the healthcare provider.

Gallium (68ga) Chloride may interact with other medications or substances. It is advisable to inform healthcare professionals about all current medications and supplements before undergoing any diagnostic procedure involving this radiopharmaceutical. This helps in minimizing potential interactions and ensuring the accuracy of the imaging results.